Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer

NCT00044291 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

865

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Neoplasms
Neoplasms, Hormone-dependent

Interventions

DRUG: atamestane
DRUG: toremifene
DRUG: letrozole
DRUG: aromatase inhibition
PROCEDURE: hormone therapy
PROCEDURE: endocrine therapy
PROCEDURE: antiestrogen therapy

Sponsor

Intarcia Therapeutics